477260-11-0

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 73918-57-7 p-Iodophenylethylamine 

Downstream Products

• 1290118-44-3 ethyl (4E)-2-N,N-bis[2-[N',N'-bis[(ethoxycarbonyl)methyl]amino]ethyl]amino-5-(4-[2-[(t-butoxy)carbonylamino]ethyl]phenyl)pento-4-enolate 
• 1290118-45-4 Ethyl 2-[N,N-bis(2-{N',N'-bis[(ethoxycarbonyl)methyl]amino}ethyl)amino]-5-(4-{2-[(t-butoxy)carbonylamino]ethyl}phenyl)pentanoate 
• 1290118-46-5 5-[4-(2-aminoethyl)phenyl]-2-(N,N-bis{2-N',N'-bis[(carboxymethyl)amino]ethyl}amino)pentanoic acid 
• 1290118-48-7 ethyl 2-[bis(2-{bis[(ethoxycarbonyl)methyl]amino}ethyl)]-5-{4-[2-(2,5-dioxoazolinyl)ethyl]phenyl}pentanoate 
• 1290118-57-8 ethyl 2-[N,N-bis(2-{N',N'-bis[(ethoxycarbonyl)methyl]amino}ethyl)amino]-5-{4-[2-({4-butyn-1-yl}carbonylamino)ethyl]phenyl}pentanoate 
• 1309680-31-6 C₄₀H₆₄N₄O₁₂ 

Relevant academic research and scientific papers

PROCESS FOR PREPARATION OF DIETHYLENETRIAMINEPENTAACETIC ACID DERIVATIVE, AND DIETHYLENETRIAMINEPENTAACETIC ACID DERIVATIVE

The objective of the present invention is to provide a process for simple and efficient preparation of an intermediate compound to synthesize a gadolinium complex having a substituent for improving a retention property in blood time and specificity to an